Personalized Nutrition Market By Product Type (Dietary Supplements, Functional Foods and Beverages, Nutraceuticals, Sports Nutrition Products, Others), By Application (Gut Health, Weight Management, Sports Performance, General Health and Wellness, Others), By Dosage Form (Tablets, Capsules, Powders, Liquids, Others), By Distribution Channel (Online {Direct to consumer, Retail Stores, Pharmacies, Others}, Online), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & forecast parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Personalized Nutrition Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. Increasing consumer demand for personalized health solutions

3.2.2. Advancements in AI and genomics for tailored nutrition

3.2.3. Rising awareness of chronic disease prevention and wellness

3.3. Key industry pitfalls & challenges

3.3.1. High cost of personalized nutrition services and products

3.3.2. Limited consumer knowledge about personalized nutrition benefits

3.3.3. Privacy concerns related to health data collection and usage

3.4. Market Opportunities

3.4.1. Expansion of personalized nutrition apps and digital platforms

3.4.2. Growth in functional foods and nutraceuticals market segments

3.4.3. Increasing partnerships between tech companies and nutritionists

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Personalized Nutrition Market, Product Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Product Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Dietary Supplements

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Functional Foods and Beverages

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Nutraceuticals

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Sports Nutrition Products

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6. Others

4.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Personalized Nutrition Market, Application Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Application, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Gut Health

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Weight Management

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Sports Performance

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. General Health and Wellness

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Others

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Personalized Nutrition Market, Dosage Form Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Dosage Form, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Tablets

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Capsules

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Powders

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Liquids

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.6. Others

6.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Personalized Nutrition Market, Distribution Channel Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Distribution Channel, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Offline

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.2.2. Direct to Consumer

7.2.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.2.3. Retail Stores

7.2.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.2.4. Pharmacies

7.2.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.2.5. Others

7.2.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Online

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Personalized Nutrition Market, Region Segment Analysis

8.1. Overview

8.1.1. Global Market Revenue Share, By Region, 2025 & 2035

8.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

8.2. North America

8.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

8.2.2. North America Market Revenue, By Product Type, 2025-2035

8.2.3. North America Market Revenue, By Application, 2025-2035

8.2.4. North America Market Revenue, By Dosage Form, 2025-2035

8.2.5. North America Market Revenue, By Distribution Channel, 2025-2035

8.2.6. The U.S.

8.2.6.1. U.S. Market Revenue, By Product Type, 2025-2035

8.2.6.2. U.S. Market Revenue, By Application, 2025-2035

8.2.6.3. U.S. Market Revenue, By Dosage Form, 2025-2035

8.2.6.4. U.S. Market Revenue, By Distribution Channel, 2025-2035

8.2.7. Canada

8.2.7.1. Canada Market Revenue, By Product Type, 2025-2035

8.2.7.2. Canada Market Revenue, By Application, 2025-2035

8.2.7.3. Canada Market Revenue, By Dosage Form, 2025-2035

8.2.7.4. Canada Market Revenue, By Distribution Channel, 2025-2035

8.3. Europe

8.3.1. Europe Market Revenue, By Country, 2025-2035 (USD Billion)

8.3.2. Europe Market Revenue, By Product Type, 2025-2035

8.3.3. Europe Market Revenue, By Application, 2025-2035

8.3.4. Europe Market Revenue, By Dosage Form, 2025-2035

8.3.5. Europe Market Revenue, By Distribution Channel, 2025-2035

8.3.6. Germany

8.3.6.1. Germany Market Revenue, By Product Type, 2025-2035

8.3.6.2. Germany Market Revenue, By Application, 2025-2035

8.3.6.3. Germany Market Revenue, By Dosage Form, 2025-2035

8.3.6.4. Germany Market Revenue, By Distribution Channel, 2025-2035

8.3.7. France

8.3.7.1. France Market Revenue, By Product Type, 2025-2035

8.3.7.2. France Market Revenue, By Application, 2025-2035

8.3.7.3. France Market Revenue, By Dosage Form, 2025-2035

8.3.7.4. France Market Revenue, By Distribution Channel, 2025-2035

8.3.8. U.K.

8.3.8.1. U.K. Market Revenue, By Product Type, 2025-2035

8.3.8.2. U.K. Market Revenue, By Application, 2025-2035

8.3.8.3. U.K. Market Revenue, By Dosage Form, 2025-2035

8.3.8.4. U.K. Market Revenue, By Distribution Channel, 2025-2035

8.3.9. Italy

8.3.9.1. Italy Market Revenue, By Product Type, 2025-2035

8.3.9.2. Italy Market Revenue, By Application, 2025-2035

8.3.9.3. Italy Market Revenue, By Dosage Form, 2025-2035

8.3.9.4. Italy Market Revenue, By Distribution Channel, 2025-2035

8.3.10. Spain

8.3.10.1. Spain Market Revenue, By Product Type, 2025-2035

8.3.10.2. Spain Market Revenue, By Application, 2025-2035

8.3.10.3. Spain Market Revenue, By Dosage Form, 2025-2035

8.3.10.4. Spain Market Revenue, By Distribution Channel, 2025-2035

8.3.11. Rest of Europe

8.3.11.1. Rest of Europe Market Revenue, By Product Type, 2025-2035

8.3.11.2. Rest of Europe Market Revenue, By Application, 2025-2035

8.3.11.3. Rest of Europe Market Revenue, By Dosage Form, 2025-2035

8.3.11.4. Rest of Europe Market Revenue, By Distribution Channel, 2025-2035

8.4. Asia Pacific

8.4.1. Asia Pacific Market Revenue, By Country, 2025-2035 (USD Billion)

8.4.2. Asia Pacific Market Revenue, By Product Type, 2025-2035

8.4.3. Asia Pacific Market Revenue, By Application, 2025-2035

8.4.4. Asia Pacific Market Revenue, By Dosage Form, 2025-2035

8.4.5. Asia Pacific Market Revenue, By Distribution Channel, 2025-2035

8.4.6. China

8.4.6.1. China Market Revenue, By Product Type, 2025-2035

8.4.6.2. China Market Revenue, By Application, 2025-2035

8.4.6.3. China Market Revenue, By Dosage Form, 2025-2035

8.4.6.4. China Market Revenue, By Distribution Channel, 2025-2035

8.4.7. Japan

8.4.7.1. Japan Market Revenue, By Product Type, 2025-2035

8.4.7.2. Japan Market Revenue, By Application, 2025-2035

8.4.7.3. Japan Market Revenue, By Dosage Form, 2025-2035

8.4.7.4. Japan Market Revenue, By Distribution Channel, 2025-2035

8.4.8. India

8.4.8.1. India Market Revenue, By Product Type, 2025-2035

8.4.8.2. India Market Revenue, By Application, 2025-2035

8.4.8.3. India Market Revenue, By Dosage Form, 2025-2035

8.4.8.4. India Market Revenue, By Distribution Channel, 2025-2035

8.4.9. Australia

8.4.9.1. Australia Market Revenue, By Product Type, 2025-2035

8.4.9.2. Australia Market Revenue, By Application, 2025-2035

8.4.9.3. Australia Market Revenue, By Dosage Form, 2025-2035

8.4.9.4. Australia Market Revenue, By Distribution Channel, 2025-2035

8.4.10. South Korea

8.4.10.1. South Korea Market Revenue, By Product Type, 2025-2035

8.4.10.2. South Korea Market Revenue, By Application, 2025-2035

8.4.10.3. South Korea Market Revenue, By Dosage Form, 2025-2035

8.4.10.4. South Korea Market Revenue, By Distribution Channel, 2025-2035

8.4.11. Singapore

8.4.11.1. Singapore Market Revenue, By Product Type, 2025-2035

8.4.11.2. Singapore Market Revenue, By Application, 2025-2035

8.4.11.3. Singapore Market Revenue, By Dosage Form, 2025-2035

8.4.11.4. Singapore Market Revenue, By Distribution Channel, 2025-2035

8.4.12. Rest of Asia Pacific

8.4.12.1. Rest of Asia Pacific Market Revenue, By Product Type, 2025-2035

8.4.12.2. Rest of Asia Pacific Market Revenue, By Application, 2025-2035

8.4.12.3. Rest of Asia Pacific Market Revenue, By Dosage Form, 2025-2035

8.4.12.4. Rest of Asia Pacific Market Revenue, By Distribution Channel, 2025-2035

8.5. Latin America

8.5.1. Latin America Market Revenue, By Country, 2025-2035 (USD Billion)

8.5.2. Latin America Market Revenue, By Product Type, 2025-2035

8.5.3. Latin America Market Revenue, By Application, 2025-2035

8.5.4. Latin America Market Revenue, By Dosage Form, 2025-2035

8.5.5. Latin America Market Revenue, By Distribution Channel, 2025-2035

8.5.6. Brazil

8.5.6.1. Brazil Market Revenue, By Product Type, 2025-2035

8.5.6.2. Brazil Market Revenue, By Application, 2025-2035

8.5.6.3. Brazil Market Revenue, By Dosage Form, 2025-2035

8.5.6.4. Brazil Market Revenue, By Distribution Channel, 2025-2035

8.5.7. Argentina

8.5.7.1. Argentina Market Revenue, By Product Type, 2025-2035

8.5.7.2. Argentina Market Revenue, By Application, 2025-2035

8.5.7.3. Argentina Market Revenue, By Dosage Form, 2025-2035

8.5.7.4. Argentina Market Revenue, By Distribution Channel, 2025-2035

8.5.8. Mexico

8.5.8.1. Mexico Market Revenue, By Product Type, 2025-2035

8.5.8.2. Mexico Market Revenue, By Application, 2025-2035

8.5.8.3. Mexico Market Revenue, By Dosage Form, 2025-2035

8.5.8.4. Mexico Market Revenue, By Distribution Channel, 2025-2035

8.5.9. Rest of Latin America

8.5.9.1. Rest of Latin America Market Revenue, By Product Type, 2025-2035

8.5.9.2. Rest of Latin America Revenue, By Application, 2025-2035

8.5.9.3. Rest of Latin America Market Revenue, By Dosage Form, 2025-2035

8.5.9.4. Rest of Latin America Market Revenue, By Distribution Channel, 2025-2035

8.6. MEA

8.6.1. MEA Market Revenue, By Country, 2025-2035 (USD Billion)

8.6.2. MEA Market Revenue, By Product Type, 2025-2035

8.6.3. MEA Market Revenue, By Application, 2025-2035

8.6.4. MEA Market Revenue, By Dosage Form, 2025-2035

8.6.5. MEA Market Revenue, By Distribution Channel, 2025-2035

8.6.6. GCC Countries

8.6.6.1. GCC Countries Market Revenue, By Product Type, 2025-2035

8.6.6.2. GCC Countries Market Revenue, By Application, 2025-2035

8.6.6.3. GCC Countries Market Revenue, By Dosage Form, 2025-2035

8.6.6.4. GCC Countries Market Revenue, By Distribution Channel, 2025-2035

8.6.7. South Africa

8.6.7.1. South Africa Market Revenue, By Product Type, 2025-2035

8.6.7.2. South Africa Market Revenue, By Application, 2025-2035

8.6.7.3. South Africa Market Revenue, By Dosage Form, 2025-2035

8.6.7.4. South Africa Market Revenue, By Distribution Channel, 2025-2035

8.6.8. Rest of Middle-East & Africa

8.6.8.1. Rest of Middle-East & Africa Market Revenue, By Product Type, 2025-2035

8.6.8.2. Rest of Middle-East & Africa Market Revenue, By Application, 2025-2035

8.6.8.3. Rest of Middle-East & Africa Market Revenue, By Dosage Form, 2025-2035

8.6.8.4. Rest of Middle-East Africa Market Revenue, By Distribution Channel, 2025-2035

9. Company Profile

9.1. Nestlé Health Science

9.1.1. Business Overview

9.1.2. Financial Performance

9.1.3. Product/Service Offerings

9.1.4. Strategies & recent developments

9.1.5. SWOT Analysis

9.2. Herbalife Nutrition Ltd.

9.2.1. Business Overview

9.2.2. Financial Performance

9.2.3. Product/Service Offerings

9.2.4. Strategies & recent developments

9.2.5. SWOT Analysis

9.3. Glanbia PLC

9.3.1. Business Overview

9.3.2. Financial Performance

9.3.3. Product/Service Offerings

9.3.4. Strategies & recent developments

9.3.5. SWOT Analysis

9.4. Dole Food Company, Inc.

9.4.1. Business Overview

9.4.2. Financial Performance

9.4.3. Product/Service Offerings

9.4.4. Strategies & recent developments

9.4.5. SWOT Analysis

9.5. Kerry Group PLC

9.5.1. Business Overview

9.5.2. Financial Performance

9.5.3. Product/Service Offerings

9.5.4. Strategies & recent developments

9.5.5. SWOT Analysis

9.6. Amway Corporation

9.6.1. Business Overview

9.6.2. Financial Performance

9.6.3. Product/Service Offerings

9.6.4. Strategies & recent developments

9.6.5. SWOT Analysis

9.7. Bayer AG

9.7.1. Business Overview

9.7.2. Financial Performance

9.7.3. Product/Service Offerings

9.7.4. Strategies & recent developments

9.7.5. SWOT Analysis

9.8. DNAfit

9.8.1. Business Overview

9.8.2. Financial Performance

9.8.3. Product/Service Offerings

9.8.4. Strategies & recent developments

9.8.5. SWOT Analysis

9.9. Habit

9.9.1. Business Overview

9.9.2. Financial Performance

9.9.3. Product/Service Offerings

9.9.4. Strategies & recent developments

9.9.5. SWOT Analysis

9.10. Zoe

9.10.1. Business Overview

9.10.2. Financial Performance

9.10.3. Product/Service Offerings

9.10.4. Strategies & recent developments

9.10.5. SWOT Analysis

9.11. Pure Encapsulations

9.11.1. Business Overview

9.11.2. Financial Performance

9.11.3. Product/Service Offerings

9.11.4. Strategies & recent developments

9.11.5. SWOT Analysis

9.12. Thorne Research

9.12.1. Business Overview

9.12.2. Financial Performance

9.12.3. Product/Service Offerings

9.12.4. Strategies & recent developments

9.12.5. SWOT Analysis

9.13. InsideTracker

9.13.1. Business Overview

9.13.2. Financial Performance

9.13.3. Product/Service Offerings

9.13.4. Strategies & recent developments

9.13.5. SWOT Analysis

9.14. Benevolent Healthcare

9.14.1. Business Overview

9.14.2. Financial Performance

9.14.3. Product/Service Offerings

9.14.4. Strategies & recent developments

9.14.5. SWOT Analysis

9.15. Nutrigenomix

9.15.1. Business Overview

9.15.2. Financial Performance

9.15.3. Product/Service Offerings

9.15.4. Strategies & recent developments

9.15.5. SWOT Analysis

9.16. DayTwo

9.16.1. Business Overview

9.16.2. Financial Performance

9.16.3. Product/Service Offerings

9.16.4. Strategies & recent developments

9.16.5. SWOT Analysis

9.17. DNAlysis Biotechnology

9.17.1. Business Overview

9.17.2. Financial Performance

9.17.3. Product/Service Offerings

9.17.4. Strategies & recent developments

9.17.5. SWOT Analysis